Clinical use comparison of a semiautomated PCR with fluorescent ribotyping for typing of Clostridium difficile.

about

Clinical use comparison of a semiautomated PCR with fluorescent ribotyping for typing of Clostridium difficile.

Item

http://www.wikidata.org/entity/Q36161086

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Clinical use comparison of a s ...... ping of Clostridium difficile.

@ast

Clinical use comparison of a s ...... ping of Clostridium difficile.

@en

type

Item

label

Clinical use comparison of a s ...... ping of Clostridium difficile.

@ast

Clinical use comparison of a s ...... ping of Clostridium difficile.

@en

prefLabel

Clinical use comparison of a s ...... ping of Clostridium difficile.

@ast

Clinical use comparison of a s ...... ping of Clostridium difficile.

@en

P1476

Clinical use comparison of a s ...... ping of Clostridium difficile.

@en

P2093

Carey-Ann D Burnham

http://www.w3.org/2001/XMLSchema#string

David P Nicolau

http://www.w3.org/2001/XMLSchema#string

M Jahangir Alam

http://www.w3.org/2001/XMLSchema#string

P2860

Development and validation of an internationally-standardized, high-resolution capillary gel-based electrophoresis PCR-ribotyping protocol for Clostridium difficile

Comparison of a commercially available repetitive-element PCR system (DiversiLab) with PCR ribotyping for typing of clostridium difficile strains

Evaluation of portability and cost of a fluorescent PCR ribotyping protocol for Clostridium difficile epidemiology.

In the Endemic Setting, Clostridium difficile Ribotype 027 Is Virulent But Not Hypervirulent.

Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.

Molecular methods for detecting and typing of Clostridium difficile.

Emergence of new PCR ribotypes from the hypervirulent Clostridium difficile 027 lineage.

Assessment of Clostridium difficile Burden in Patients Over Time With First Episode Infection Following Fidaxomicin or Vancomycin.

Whole-genome sequencing improves discrimination of relapse from reinfection and identifies transmission events among patients with recurrent Clostridium difficile infections.

P2888

s00203-016-1305-6

P304

317-323

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00203-016-1305-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

199

http://www.w3.org/2001/XMLSchema#string

P50

Abrar K Thabit

P577

2016-10-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27730251

http://www.w3.org/2001/XMLSchema#string